SEARCH BY
Evaluate is a provider of commercial intelligence to the global life sciences industry. Evaluate is the trusted provider of mission critical commercial information for complex business decisions to the pharmaceutical industry. Evaluate’s core product is an industry leading set of analyst consensus forecasts that provides detailed insights at the product, disease, indication and geographic level. Evaluate creates value by structuring, normalising and integrating data from company filings, research organisations, and government bodies and providing tools that drive analytical insights from data. Evaluate was the first mover in this particular space and is a leading provider today. Evaluate was founded in 1996 and is based in London, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 5 |
| Sector: Business Services M&A | 3 of 3 |
| Type: Add-on Acquisition M&A Deals | 4 of 4 |
| Country: United Kingdom M&A | 2 of 2 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-28 |
Panalgo
Boston, Massachusetts, United States Panalgo provides software that streamlines healthcare data analytics by removing complex programming from the equation. Panalgo Instant Health Data (IHD) software empowers teams to generate and share trustworthy results faster, enabling more impactful decisions. Panalgo was established in 1996 and is based in Boston, Massachusetts. |
Buy | - |
